AXIM Featured by Reuters: Biotech Receives Cannabis Strains at “Discount for Gum to Treat Multiple Sclerosis”
January 05, 2016 13:39 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Jan. 05, 2016 (GLOBE NEWSWIRE) -- A groundbreaking story by Reuters global news agency profiled AXIM® Biotechnologies, Inc. (OTC:AXIM) and the company’s upcoming clinical trials on the...
Photo Release -- AXIM Biotech Announces Hemp Innovations for Life Sciences
June 04, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, June 4, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical,...